The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Motegi, Y.
Right arrow Articles by Kita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motegi, Y.
Right arrow Articles by Kita, H.
The Journal of Immunology, 1998, 161: 4340-4346.
Copyright © 1998 by The American Association of Immunologists

Interaction with Secretory Component Stimulates Effector Functions of Human Eosinophils But Not of Neutrophils1

Youichi Motegi and Hirohito Kita2

Department of Immunology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905

Eosinophils and their products are important in the pathophysiology of allergic inflammation in mucosal tissues. Secretory component bound to IgA mediates transepithelial transport of IgA and confers increased stability on the resultant secretory IgA; however, the effect of secretory component on the biologic activity of IgA is unknown. Here, we report that secretory IgA and secretory component preferentially activate human eosinophils. When eosinophils were stimulated with immobilized secretory IgA, degranulation and superoxide production were two- to threefold greater than when stimulated with serum IgA. In contrast, neutrophils responded similarly to secretory IgA and serum IgA. Flow cytometric analysis showed that eosinophils bound to purified secretory component. The binding of 125I-labeled secretory component was inhibited by unlabeled secretory component or secretory IgA but not by serum IgA. Superoxide production by eosinophils stimulated with cytokines or IgG was enhanced synergistically by immobilized secretory component; secretory component showed no effect on neutrophil activation. Finally, anti-CD18 mAb abolished eosinophil superoxide production stimulated with secretory IgA or secretory component but not with serum IgA, suggesting a crucial role for ß2 integrins in eosinophil interactions with secretory IgA or secretory component. Thus, secretory component plays important roles in activating eosinophil functions but not neutrophil functions. This preferential interaction between secretory component and eosinophils may provide a novel mechanism to regulate mucosal tissue inflammation.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
E. Evans, W. Zhang, G. Jerdeva, C.-Y. Chen, X. Chen, S. F. Hamm-Alvarez, and C. T. Okamoto
Direct interaction between Rab3D and the polymeric immunoglobulin receptor and trafficking through regulated secretory vesicles in lacrimal gland acinar cells
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C662 - C674.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. E. Fasching, T. Grossman, B. Corthesy, A. G. Plaut, J. N. Weiser, and E. N. Janoff
Impact of the Molecular Form of Immunoglobulin A on Functional Activity in Defense against Streptococcus pneumoniae
Infect. Immun., April 1, 2007; 75(4): 1801 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Wu, C. Ji, F. Xie, C. D. Langefeld, K. Qian, A. W. Gibson, J. C. Edberg, and R. P. Kimberly
Fc{alpha}RI (CD89) Alleles Determine the Proinflammatory Potential of Serum IgA
J. Immunol., March 15, 2007; 178(6): 3973 - 3982.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Matsuyama, H. Mitsuyama, M. Ono, Y. Shirahama, I. Higashimoto, M. Osame, and K. Arimura
Discoidin domain receptor 1 contributes to eosinophil survival in an NF-{kappa}B-dependent manner in Churg-Strauss syndrome
Blood, January 1, 2007; 109(1): 22 - 30.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Schettini, G. Salamone, A. Trevani, S. Raiden, R. Gamberale, M. Vermeulen, M. Giordano, and J. R. Geffner
Stimulation of neutrophil apoptosis by immobilized IgA
J. Leukoc. Biol., October 1, 2002; 72(4): 685 - 691.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. B. van Spriel, J. H. W. Leusen, H. Vile, and J. G. J. van de Winkel
Mac-1 (CD11b/CD18) as Accessory Molecule for Fc{alpha}R (CD89) Binding of IgA
J. Immunol., October 1, 2002; 169(7): 3831 - 3836.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. L. Thomas, W. Xu, and T. T. Ardon
Immobilized Lactoferrin Is a Stimulus for Eosinophil Activation
J. Immunol., July 15, 2002; 169(2): 993 - 999.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Nakata, O. Kaminuma, K. Ogawa, H. Fujimura, K. Fushimi, H. Kikkawa, K. Naito, K. Ikezawa, R. W. Egan, and A. Mori
Correlation between eosinophilia induced by CD4+ T cells and bronchial hyper-responsiveness
Int. Immunol., March 1, 2001; 13(3): 329 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.